Emergency Access to Insulin Act of 2019
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Jul 25, 2019)
Emergency Access to Insulin Act of 2019
This bill reduces the marketing exclusivity period for biological drug products from 12 to 7 years and establishes policies and programs designed to increase access to prescription insulin. Specifically, the bill requires the Centers for Disease Control and Prevention to award grants to states to create insulin card programs, which provide uninsured or underinsured individuals with insulin at no cost for specified time periods. Payments for insulin prescriptions made through the program must count toward an underinsured individual’s health plan deductible. Further, the Department of Health and Human Services (HHS) must collect annual fees from insulin manufacturers, based on each manufacturer’s market share, equal to the total estimated expenditures under the insulin grants program.
Subject to certain exceptions, the bill also establishes an excise tax on insulin manufacturers when the price of an insulin product spikes. The tax amount is a specified percentage of the revenue a manufacturer received as a result of the price spike. The tax amount increases in tiers based on the percentage of the price spike for that product.
What just happenedJul 26, 2019
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseJul 25, 2019
- Jul 26, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jul 25, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jul 25, 2019IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Jul 25, 2019IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Jul 25, 2019IntroReferralIntro-H
Introduced in House
- Jul 25, 2019IntroReferral1000
Introduced in House